BACKGROUND: Interval colorectal cancer (CRC) accounts for 3% to 8% of all cases of CRC in the United States. Data on interval CRC by race/ethnicity are scant. OBJECTIVE: To examine whether risk for interval CRC among Medicare patients differs by race/ethnicity and whether this potential variation is accounted for by differences in the quality of colonoscopy, as measured by physicians' polyp detection rate (PDR). DESIGN: Population-based cohort study. SETTING: Medicare program. PARTICIPANTS: Patients aged 66 to 75 years who received colonoscopy between 2002 and 2011 and were followed through 2013. MEASUREMENTS: Kaplan-Meier curves and adjusted Cox models were used to estimate cumulative probabilities and hazard ratios (HRs) of interval CRC, defined as a CRC diagnosis 6 to 59 months after colonoscopy. RESULTS: There were 2735 cases of interval CRC identified over 235 146 person-years of follow-up. A higher proportion of black persons (52.8%) than white persons (46.2%) received colonoscopy from physicians with a lower PDR. This rate was significantly associated with interval CRC risk. The probability of interval CRC by the end of follow-up was 7.1% in black persons and 5.8% in white persons. Compared with white persons, black persons had significantly higher risk for interval CRC (HR, 1.31 [95% CI, 1.13 to 1.51]); the disparity was more pronounced for cancer of the rectum (HR, 1.70 [CI, 1.25 to 2.31]) and distal colon (HR, 1.45 [CI, 1.00 to 2.11]) than for cancer of the proximal colon (HR, 1.17 [CI, 0.96 to 1.42]). Adjustment for PDR did not alter HRs by race/ethnicity, but differences between black persons and white persons were greater among physicians with higher PDRs. LIMITATION: Colonoscopy and polypectomy were identified by using billing codes. CONCLUSION: Among elderly Medicare enrollees, the risk for interval CRC was higher in black persons than in white persons; the difference was more pronounced for cancer of the distal colon and rectum and for physicians with higher PDRs. PRIMARY FUNDING SOURCE: American Cancer Society.
BACKGROUND: Interval colorectal cancer (CRC) accounts for 3% to 8% of all cases of CRC in the United States. Data on interval CRC by race/ethnicity are scant. OBJECTIVE: To examine whether risk for interval CRC among Medicare patients differs by race/ethnicity and whether this potential variation is accounted for by differences in the quality of colonoscopy, as measured by physicians' polyp detection rate (PDR). DESIGN: Population-based cohort study. SETTING: Medicare program. PARTICIPANTS: Patients aged 66 to 75 years who received colonoscopy between 2002 and 2011 and were followed through 2013. MEASUREMENTS: Kaplan-Meier curves and adjusted Cox models were used to estimate cumulative probabilities and hazard ratios (HRs) of interval CRC, defined as a CRC diagnosis 6 to 59 months after colonoscopy. RESULTS: There were 2735 cases of interval CRC identified over 235 146 person-years of follow-up. A higher proportion of black persons (52.8%) than white persons (46.2%) received colonoscopy from physicians with a lower PDR. This rate was significantly associated with interval CRC risk. The probability of interval CRC by the end of follow-up was 7.1% in black persons and 5.8% in white persons. Compared with white persons, black persons had significantly higher risk for interval CRC (HR, 1.31 [95% CI, 1.13 to 1.51]); the disparity was more pronounced for cancer of the rectum (HR, 1.70 [CI, 1.25 to 2.31]) and distal colon (HR, 1.45 [CI, 1.00 to 2.11]) than for cancer of the proximal colon (HR, 1.17 [CI, 0.96 to 1.42]). Adjustment for PDR did not alter HRs by race/ethnicity, but differences between black persons and white persons were greater among physicians with higher PDRs. LIMITATION: Colonoscopy and polypectomy were identified by using billing codes. CONCLUSION: Among elderly Medicare enrollees, the risk for interval CRC was higher in black persons than in white persons; the difference was more pronounced for cancer of the distal colon and rectum and for physicians with higher PDRs. PRIMARY FUNDING SOURCE: American Cancer Society.
Authors: A V Diez-Roux; C I Kiefe; D R Jacobs; M Haan; S A Jackson; F J Nieto; C C Paton; R Schulz; A V Roux Journal: Ann Epidemiol Date: 2001-08 Impact factor: 3.797
Authors: Anna P Schenck; Carrie N Klabunde; Joan L Warren; Sharon Peacock; William W Davis; Sarah T Hawley; Michael Pignone; David F Ransohoff Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-10 Impact factor: 4.254
Authors: J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham Journal: Lancet Date: 1996-11-30 Impact factor: 79.321
Authors: John M Carethers; Bhavya Murali; Bing Yang; Ryan T Doctolero; Akihiro Tajima; Ranor Basa; E Julieta Smith; Monte Lee; Ryan Janke; Tina Ngo; Ruth Tejada; Ming Ji; Matthew Kinseth; Betty L Cabrera; Katsumi Miyai; Temitope O Keku; Christopher F Martin; Joseph A Galanko; Robert S Sandler; Kathleen L McGuire Journal: PLoS One Date: 2014-06-23 Impact factor: 3.240
Authors: Chyke A Doubeni; Stacey A Fedewa; Theodore R Levin; Christopher D Jensen; Chelsea Saia; Alexis M Zebrowski; Virginia P Quinn; Katharine A Rendle; Ann G Zauber; Tracy A Becerra-Culqui; Shivan J Mehta; Robert H Fletcher; Joanne Schottinger; Douglas A Corley Journal: Gastroenterology Date: 2018-09-27 Impact factor: 22.682
Authors: Lindsey A Jones; Katherine C Brewer; Leslie R Carnahan; Jennifer A Parsons; Blase N Polite; Carol Estwing Ferrans; Richard B Warnecke; Garth H Rauscher Journal: Public Health Rep Date: 2021-03-31 Impact factor: 2.792
Authors: Chyke A Doubeni; Nicole B Gabler; Cosette M Wheeler; Anne Marie McCarthy; Philip E Castle; Ethan A Halm; Mitchell D Schnall; Celette S Skinner; Anna N A Tosteson; Donald L Weaver; Anil Vachani; Shivan J Mehta; Katharine A Rendle; Stacey A Fedewa; Douglas A Corley; Katrina Armstrong Journal: CA Cancer J Clin Date: 2018-03-30 Impact factor: 508.702
Authors: Mohammed Al-Sadawi; Yasin Hussain; Robert S Copeland-Halperin; Jonathan N Tobin; Chaya S Moskowitz; Chau T Dang; Jennifer E Liu; Richard M Steingart; Michelle N Johnson; Anthony F Yu Journal: Am J Cardiol Date: 2021-02-20 Impact factor: 2.778
Authors: Robert S Bresalier; William M Grady; Sanford D Markowitz; Hans Jørgen Nielsen; Surinder K Batra; Paul D Lampe Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-04-16 Impact factor: 4.254